Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 17 | Tamari ShaharDirector, COO | Open-market sale · 10b5-1 plan | SELL | $260K 8,333 sh | Apr 8, 2026 |
| 17 | Stone Melissa AnnEVP and Interim CFO | Grant or award | A | — 3,712 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 17 | Graf Erik W.EVP, Controller | Grant or award | A | — 3,712 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 17 | Gowasack Andrew CarlDirector, President | Option exercise | M | — 13.5K sh | Apr 8, 2026 traded Apr 6, 2026 |
| 17 | Griffith JesseChief Operations Officer | Open-market sale | SELL | $3,053 1,008 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 17 | Boone KarenDirector | Option exercise | M | — 1,460 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 17 | McClintock WilliamDirector | Option exercise | M | — 52 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 17 | Wilson Lance RobertChief Financial Officer | Option exercise | M | — 4,120 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 17 | Buckley MerileeCHIEF ACCOUNTING OFFICER | Open-market sale · 10b5-1 plan | SELL | $37K 687 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 17 | McCrystle Kevin RossCOO | Option exercise | M | — 17.7K sh | Apr 8, 2026 traded Apr 6, 2026 |
| 17 | Subrahmanyam AmbaChief People Officer | Grant or award | A | — 6,808 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 17 | Gillespie CharlesCEO | Option exercise | M | — 22.8K sh | Apr 8, 2026 traded Apr 6, 2026 |
| 17 | Wilson Lance RobertChief Financial Officer | Option exercise | M | — 2,637 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 17 | Ming TracyFinancial Controller | Tax withholding | F | $2,647 1,018 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 17 | Wilson Lance RobertChief Financial Officer | Option exercise | M | — 2,637 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 17 | Wilson Lance RobertChief Financial Officer | Option exercise | M | — 1,780 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 17 | McClintock WilliamDirector | Option exercise | M | — 52 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 17 | Buckley MerileeCHIEF ACCOUNTING OFFICER | Open-market sale · 10b5-1 plan | SELL | $6,586 122 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 17 | Refsgaard CorinnaChief Human Resources Officer | Option exercise | M | — 2,676 sh | Apr 8, 2026 traded Apr 8, 2026 |
| 17 | Kohler DonaldCEO, PVH Americas | Grant or award | A | — 8,352 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 16 | Valente ManuelaChief People Officer | Open-market sale · 10b5-1 plan | SELL | $13K 2,597 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 16 | Muken RossPresident | Open-market sale · 10b5-1 plan | SELL | $13K 2,600 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 16 | Camblong JurgiDirector, Chief Executive Officer | Open-market sale · 10b5-1 plan | SELL | $13K 2,600 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 16 | Valente ManuelaChief People Officer | Open-market sale · 10b5-1 plan | SELL | $12K 2,376 sh | Apr 8, 2026 traded Apr 7, 2026 |
| 16 | Gillespie CharlesCEO | Option exercise | M | $87K 22.8K sh | Apr 8, 2026 traded Apr 6, 2026 |
| 16 | Muken RossPresident | Open-market sale · 10b5-1 plan | SELL | $12K 2,424 sh | Apr 8, 2026 traded Apr 7, 2026 |
| 16 | Menu PhilippeChief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $12K 2,400 sh | Apr 8, 2026 traded Apr 7, 2026 |
| 16 | Doyle MittieChief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $72K 3,970 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 16 | Cardoza GeorgeChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $12K 2,413 sh | Apr 8, 2026 traded Apr 7, 2026 |
| 16 | Prince MatthewDirector, CEO & Board Co-Chair, 10% Owner | Open-market sale · 10b5-1 plan | SELL | $118K 567 sh | Apr 8, 2026 traded Apr 7, 2026 |
| 16 | Xu ZhenyuChief Scientific Officer | Open-market sale · 10b5-1 plan | SELL | $12K 2,400 sh | Apr 8, 2026 traded Apr 7, 2026 |
| 16 | Byron DonaldsRSpouse | Sale | SELL | $1,001 – $15K | Apr 8, 2026 traded Mar 20, 2026 |
| 16 | Menu PhilippeChief Medical Officer | Open-market sale · 10b5-1 plan | SELL | $13K 2,700 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 16 | Byron DonaldsRSelf | Sale | SELL | $1,001 – $15K | Apr 8, 2026 traded Mar 20, 2026 |
| 16 | Verma AbhimanyuChief Technology Officer | Open-market sale · 10b5-1 plan | SELL | $5,016 1,030 sh | Apr 8, 2026 traded Apr 7, 2026 |
| 16 | Kohler DonaldCEO, PVH Americas | Tax withholding | F | $154K 1,902 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 16 | Van Well DaanChief Legal Officer | Open-market sale · 10b5-1 plan | SELL | $12K 2,400 sh | Apr 8, 2026 traded Apr 7, 2026 |
| 16 | Cardoza GeorgeChief Financial Officer | Open-market sale · 10b5-1 plan | SELL | $12K 2,520 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 16 | Van Well DaanChief Legal Officer | Open-market sale · 10b5-1 plan | SELL | $13K 2,705 sh | Apr 8, 2026 traded Apr 6, 2026 |
| 16 | Xu ZhenyuChief Scientific Officer | Open-market sale · 10b5-1 plan | SELL | $13K 2,700 sh | Apr 8, 2026 traded Apr 6, 2026 |